GlassScriptPhysician profile
Amir Lubarsky
NPI 1245219047
$1,439.17
in general payments reported to CMS, 2019-2025
17 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $732 · 2020: $56.38 · 2021: $43.17 · 2022: $219 · 2023: $48.08 · 2024: $83.27 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $393.71 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $163.09 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $128.85 | 2019-2020 | |
| Amgen INC. | $113.56 | 2019-2024 | Otezla, Repatha |
| Pfizer INC. | $105.88 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $91.66 | 2019-2022 | |
| Glaxosmithkline, LLC. | $72.00 | 2019-2022 | |
| Lilly USA, LLC | $55.13 | 2023-2025 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $48.77 | 2019 | |
| Cleerly, INC. | $47.49 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Regeneron Healthcare Solutions, INC. | $42.83 | 2019 | |
| Abbvie INC. | $40.34 | 2022 | |
| Astellas Pharma US INC | $36.30 | 2019 | |
| Boston Scientific Corporation | $35.23 | 2023 | Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $31.28 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $20.25 | 2019 | |
| Vertiflex, INC. | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Lubarsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.